Dr. Nicholas Turner, MD

• Infectious Disease Medicine

• Diagnostic Radiology

• Internal Medicine & Pediatrics

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Master's In Health Sciences - Clinical Research (mhsc)

  2019

• Duke University Medical Center

  Residency Hospital, 2016

• Duke University School Of Medicine

  Medical School, 2012

• University Of Wisconsin Madison

  Undergraduate School, 2008

• University Of Wisconsin-madison

  Undergraduate School, 2008

• English

• Arabic

• Uncovering the Harms of Treating Clostridioides difficile Colonization, 2021-01-13

• Methicillin-resistantStaphylococcus aureus: an overview of basic and clinical research, 2019-12-19

• Epidemiologic Trends inClostridioides difficileInfections in a Regional Community Hospital Network Trends inC difficileInfections in a Regional Hospital Network, 2019-10-30

• Investigating risk factors for urine culture contamination in outpatient clinics: A new avenue for diagnostic stewardship, 2022-03-18

• Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials, 2021-04-15

• 242. Rising Incidence ofFinegoldia magnaamong Prosthetic Joint Infections, 2021-12-04

• Novel and emerging sources ofClostridioides difficile infection, 2019-12-19

• Evaluation of a Pharmacist-Led Penicillin Allergy Assessment Program and Allergy Delabeling in a Tertiary Care Hospital Evaluation of a Pharmacist-Led Penicillin Allergy Assessment Program and Allergy Delabeling, 2021-05-13

• Using the COM-B model to identify barriers to and facilitators of evidence-based nurse urine-culture practices, 2023-03-31

• Sustained reduction in catheter-associated urinary tract infections using multi-faceted strategies led by champions: A quality improvement initiative, 2021-04-16

• Dalbavancin as an option for treatment ofS. aureusbacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial, 2022-05-16

• Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents, 2021-09-08

• Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials, 2021-05-14

• Investigating Risk Factors for Urine Culture Contamination in Outpatient Clinics: A New Avenue for Diagnostic Stewardship, 2022-02-18

• An Enhanced Strategy for Daily Disinfection in Acute Care Hospital Rooms A Randomized Clinical Trial Enhanced Strategy for Daily Disinfection in Acute Care Hospital Rooms, 2022-11-15